Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus - Furey, Colleen; Scher, Gabrielle; Ye, Naiqing; Kercher, Lisa; DeBeauchamp, Jennifer; Crumpton, Jeri Carol; Jeevan, Trushar; Patton, Christopher; Franks, John; Rubrum, Adam; Alameh, Mohamad-Gabriel; Fan, Steven H. Y.; et al. (Nature communications, 2024)
Keywords: 13; 13/106; 49; 631/1647/334/1874/345; 631/250/590/2293; 631/326/596/1578; 64; 64/60; 82/1; Animal models; Animals; Antibodies; Antibodies, Neutralizing - immunology; Antibodies, Viral - immunology; Avian flu; Birds; Birds - virology; Female; Females; Ferrets; Glycoproteins; Hemagglutinin Glycoproteins, Influenza Virus - genetics; Hemagglutinin Glycoproteins, Influenza Virus - immunology; Hemagglutinins; Humanities and Social Sciences; Humans; Immunogenicity; Influenza; Influenza A Virus, H1N1 Subtype - genetics; Influenza A Virus, H1N1 Subtype - immunology; Influenza A Virus, H5N1 Subtype - genetics; Influenza A Virus, H5N1 Subtype - immunology; Influenza in Birds - immunology; Influenza in Birds - prevention & control; Influenza in Birds - virology; Influenza Vaccines - administration & dosage; Influenza Vaccines - immunology; Lipids; Lipids - chemistry; Liposomes; Lymphocytes; Lymphocytes T; Male; Mice; Mice, Inbred BALB C; Morbidity; mRNA; mRNA Vaccines - immunology; multidisciplinary; Mustela; Nanoparticles; Nanoparticles - chemistry; Orthomyxoviridae; Orthomyxoviridae Infections - immunology; Orthomyxoviridae Infections - prevention & control; Orthomyxoviridae Infections - virology; Pandemics; RNA, Messenger - genetics; RNA, Messenger - immunology; RNA, Messenger - metabolism; Science; Science (multidisciplinary); Vaccines; Viruses